Research Paper Volume 15, Issue 24 pp 14677—14702
Identification and validation of necroptosis-related gene signatures to predict clinical outcomes and therapeutic responses in acute myeloid leukemia
Figure 2. Subtypes of necroptosis-related genes and their clinicopathological and biological characteristics in AML. (A) PCA of transcriptomes among the three identified clusters. (B) Kaplan–Meier curves showing overall survival for the three necroptosis clusters. (C) Clinicopathological characteristics and expression of necroptosis-related genes among the three necroptosis clusters.